.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Accenture
Fish and Richardson
Cantor Fitzgerald
US Department of Justice
Cerilliant
Boehringer Ingelheim
Johnson and Johnson
Deloitte
Moodys

Generated: September 25, 2017

DrugPatentWatch Database Preview

M.V.I.-12 (WITHOUT VITAMIN K) Drug Profile

« Back to Dashboard

Which patents cover M.v.i.-12 (without Vitamin K), and when can generic versions of M.v.i.-12 (without Vitamin K) launch?

M.v.i.-12 (without Vitamin K) is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in M.V.I.-12 (WITHOUT VITAMIN K) is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.

Summary for Tradename: M.V.I.-12 (WITHOUT VITAMIN K)

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list14,213